PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions

Eli Lilly and Company (LLY)

Equity · Currency in USD · Last updated Dec 2, 2023

Eli Lilly and Company is an American multinational pharmaceutical company. It was founded in 1876 and is headquartered in Indianapolis, Indiana. The company develops, manufactures, and markets a wide range of pharmaceutical products, including prescription drugs and vaccines, for various medical conditions.

SummaryFinancials

Company Info

ISINUS5324571083
CUSIP532457108
SectorHealthcare
IndustryDrug Manufacturers—General

Highlights

Market Cap$554.43B
EPS$5.55
PE Ratio105.23
PEG Ratio1.60
Revenue (TTM)$32.07B
Gross Profit (TTM)$21.91B
EBITDA (TTM)$11.32B
Year Range$307.17 - $628.81
Target Price$550.78
Short %0.74%
Short Ratio1.60

Share Price Chart


Loading data...

Performance

The chart shows the growth of an initial investment of $10,000 in Eli Lilly and Company, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%10.00%20.00%30.00%40.00%JulyAugustSeptemberOctoberNovemberDecember
32.56%
7.29%
LLY (Eli Lilly and Company)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with LLY

Eli Lilly and Company

Popular comparisons: LLY vs. NVO, LLY vs. UNH, LLY vs. XLV, LLY vs. VOO, LLY vs. DHR, LLY vs. DQ, LLY vs. VRTX, LLY vs. AGNG, LLY vs. AAPL, LLY vs. LRCX

Return

Eli Lilly and Company had a return of 61.22% year-to-date (YTD) and 59.26% in the last 12 months. Over the past 10 years, Eli Lilly and Company had an annualized return of 30.77%, outperforming the S&P 500 benchmark which had an annualized return of 9.87%.


PeriodReturnBenchmark
Year-To-Date61.22%19.67%
1 month5.53%8.42%
6 months32.56%7.29%
1 year59.26%12.71%
5 years (annualized)39.85%10.75%
10 years (annualized)30.77%9.87%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
20238.77%9.20%-3.08%22.18%-3.08%3.13%6.90%

Risk-Adjusted Performance

This table presents a comparison of risk-adjusted performance metrics for Eli Lilly and Company (LLY) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
LLY
Eli Lilly and Company
2.06
^GSPC
S&P 500
0.91

Sharpe Ratio

The current Eli Lilly and Company Sharpe ratio is 2.06. A Sharpe ratio higher than 2.0 is considered very good.


Rolling 12-month Sharpe Ratio0.000.501.001.502.002.503.003.50JulyAugustSeptemberOctoberNovemberDecember
2.06
0.91
LLY (Eli Lilly and Company)
Benchmark (^GSPC)

Dividend History

Eli Lilly and Company granted a 0.77% dividend yield in the last twelve months. The annual payout for that period amounted to $4.52 per share.


PeriodTTM20222021202020192018201720162015201420132012
Dividend$4.52$3.92$3.40$2.96$2.58$2.25$2.08$2.04$2.00$1.96$1.96$1.96

Dividend yield

0.77%1.07%1.23%1.75%1.96%1.94%2.46%2.77%2.37%2.84%3.84%3.97%

Monthly Dividends

The table displays the monthly dividend distributions for Eli Lilly and Company. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDec
2023$0.00$1.13$0.00$0.00$1.13$0.00$0.00$1.13$0.00$0.00$1.13
2022$0.00$0.98$0.00$0.00$0.98$0.00$0.00$0.98$0.00$0.00$0.98$0.00
2021$0.00$0.85$0.00$0.00$0.85$0.00$0.00$0.85$0.00$0.00$0.85$0.00
2020$0.00$0.74$0.00$0.00$0.74$0.00$0.00$0.74$0.00$0.00$0.74$0.00
2019$0.00$0.65$0.00$0.00$0.65$0.00$0.00$0.65$0.00$0.00$0.65$0.00
2018$0.00$0.56$0.00$0.00$0.56$0.00$0.00$0.56$0.00$0.00$0.56$0.00
2017$0.00$0.52$0.00$0.00$0.52$0.00$0.00$0.52$0.00$0.00$0.52$0.00
2016$0.00$0.51$0.00$0.00$0.51$0.00$0.00$0.51$0.00$0.00$0.51$0.00
2015$0.00$0.50$0.00$0.00$0.50$0.00$0.00$0.50$0.00$0.00$0.50$0.00
2014$0.00$0.49$0.00$0.00$0.49$0.00$0.00$0.49$0.00$0.00$0.49$0.00
2013$0.00$0.49$0.00$0.00$0.49$0.00$0.00$0.49$0.00$0.00$0.49$0.00
2012$0.49$0.00$0.00$0.49$0.00$0.00$0.49$0.00$0.00$0.49$0.00

Dividend Yield & Payout


Dividend Yield
LLY
0.77%
Market bottom
1.03%
Market top
5.13%
Eli Lilly and Company has a dividend yield of 0.77%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
LLY
76.35%
Market bottom
17.94%
Market top
59.27%
Eli Lilly and Company has a payout ratio of 76.35%, which is above the market average. This might signify the company's strong earnings or financial health. However, it could also hint at a more mature business phase with potentially slower growth.

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-15.00%-10.00%-5.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-5.49%
-4.21%
LLY (Eli Lilly and Company)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Eli Lilly and Company. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Eli Lilly and Company was 68.27%, occurring on Mar 5, 2009. Recovery took 1428 trading sessions.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-68.27%Aug 9, 20002154Mar 5, 20091428Nov 4, 20143582
-60.84%Jul 26, 19731051Sep 21, 19771443Jun 7, 19832494
-46.4%Jan 10, 1992404Aug 13, 1993408Mar 27, 1995812
-43.28%Mar 8, 1999254Mar 7, 200080Jun 29, 2000334
-40.74%Sep 15, 198725Oct 19, 1987353Mar 13, 1989378

Volatility Chart

The current Eli Lilly and Company volatility is 9.80%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%JulyAugustSeptemberOctoberNovemberDecember
9.80%
2.79%
LLY (Eli Lilly and Company)
Benchmark (^GSPC)